Table of Contents
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of posaconazole delayed-release tablets to its current portfolio.
Posaconazole delayed-release tablets are indicated for the prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised.
Posaconazole delayed-release 100 mg tablets are available in a 60-count bottle.
To find out more about posaconazole delayed-release tablets visit www.camberpharma.com
